Keywords
Abstract
Ushbu maqolada vitamin D ning metabolik sindrom patogenezidagi o‘rni, uning organizmda bajaradigan fiziologik vazifalari hamda vitamin D preparatlarining profilaktik va terapevtik ahamiyati yoritilgan. So‘nggi yillarda olib borilgan klinik va eksperimental tadqiqotlar vitamin D yetishmovchiligi bilan insulin rezistentligi, dislipidemiya, gipertenziya va abdominal semirish kabi metabolik sindrom komponentlari o‘rtasida yaqqol bog‘liqlik mavjudligini ko‘rsatmoqda. Maqolada vitamin D ning gormon sifatidagi ta’sir mexanizmlari, uning reseptorlar orqali ta’siri va metabolik muvozanatni tiklashdagi roli tahlil qilinadi.
References
1. Holick M.F. “Vitamin D deficiency.” New England Journal of Medicine, 2007; 357(3):266–281.
2. Pittas A.G., et al. “Vitamin D and cardiometabolic outcomes.” Annals of Internal Medicine, 2010; 152(5):307–314.
3. Griz L.H.M., et al. “Vitamin D and metabolic syndrome: A systematic review.” Clinical Nutrition, 2019; 38(1):48–54.
4. Palomer X., et al. “Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.” Diabetes, Obesity and Metabolism, 2008; 10(3):185–197.
5. Rafiq R., van Schoor N.M. “Vitamin D and cardiovascular disease: An updated narrative review.” European Journal of Preventive Cardiology, 2021; 28(2):131–146.
6. Forouhi N.G., et al. “Vitamin D and metabolic disorders in humans.” Endocrine Reviews, 2018; 39(6):456–492.
7. Al-Daghri N.M., et al. “Vitamin D supplementation and metabolic health.” Journal of Steroid Biochemistry and Molecular Biology, 2018; 175:1–8.
8. Gonçalves D., et al. “Mechanisms linking vitamin D to insulin resistance and obesity.” Cytokine & Growth Factor Reviews, 2020; 52:74–87.
9. Wimalawansa S.J. “Vitamin D and cardiovascular diseases: Causality.” Journal of Steroid Biochemistry and Molecular Biology, 2018; 175:29–43.
10. Zittermann A., et al. “Vitamin D and risk of metabolic syndrome in adults.” European Journal of Clinical Nutrition, 2016; 70(9):1026–1036.